Obinutuzumab (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Obinutuzumab" in French language version.

refsWebsite

Global rank French rank

2bloodjournal.org

low place

4,294^th place

2,374^th place

298^th place

1aacrjournals.org

8,869^th place

4,895^th place

1sciencedirect.com

149^th place

80^th place

aacrjournals.org

mct.aacrjournals.org

Herter S, Herting F, Mundigl O et al. Preclinical activity of the type II CD20 antibody GA101 (obinutuzumab) compared with rituximab and ofatumumab in vitro and in xenograft models, Mol Cancer Ther, 2013;12:2031-2042

bloodjournal.org

Mössner E, Brünker P, Moser S et al. Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell-mediated B-cell cytotoxicity, Blood, 2010;115:4393-4402
Radford J, Davies A, Cartron G et al. Obinutuzumab (GA101) plus CHOP or FC in relapsed/refractory follicular lymphoma: results of the GAUDI study (BO21000), Blood, 2013;122:1137-1143

nejm.org

Goede V, Fischer K, Busch R et al. Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions, N Engl J Med, 2014;370:1101-1110
Marcus R, Davies A, Ando K et al. Obinutuzumab for the first-line treatment of follicular lymphoma, N Engl J Med, 2017;377:1331-1344

sciencedirect.com

Sehn LH, Chua N, Mayer J et al. A randomised controlled trial of obinutuzumab plus bendamustine versus bendamustine alone in patients with rituximab-refractory indolent non-Hodgkin lymphoma: primary results of the GADOLIN study, Lancet Oncol, 2016;17:1081-1093